News
Gland Pharma’s subsidiary Cenexi gets 11 observations from French regulator, operations unaffected
In response, Cenexi has submitted a corrective and preventive action (CAPA) plan, which includes a range of measures to b ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback